| USD millions | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 1.5 | 2.3 | 4.9 | 10.0 | 6.1 | 7.7 | +25.8% | |
| Gross profit | (1.5) | (2.3) | (4.9) | (10.0) | (6.1) | (7.7) | −25.8% | |
| Research & development | 61.9 | 105.5 | 196.3 | 265.1 | 144.8 | 72.2 | −50.1% | |
| Selling, general & administrative | 29.6 | 51.5 | 75.1 | 57.3 | 45.1 | 38.8 | −14.0% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 91.4 | 157.1 | 271.5 | 322.4 | 189.9 | 111.0 | −41.5% | |
| Operating income | (91.4) | (157.1) | (271.5) | (322.4) | (196.1) | (122.2) | +37.7% | |
| Interest expense | 6.2 | 0.0 | 0.0 | 3.7 | 0.0 | 0.0 | — | |
| Interest income | 6.2 | 4.3 | 0.4 | 3.7 | 10.3 | 6.5 | −37.7% | |
| Other income / expense | 6.0 | 3.6 | 1.6 | 2.5 | 10.4 | 6.4 | −38.1% | |
| Pre-tax income | (85.4) | (153.5) | (269.9) | (320.0) | (185.7) | (115.8) | +37.6% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (85.4) | (153.5) | (269.9) | (320.0) | (185.7) | (115.8) | +37.6% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (1.72) | (3.10) | (5.01) | (5.06) | (2.14) | (1.30) | +39.3% | |
| EPS, diluted (per share) | (1.72) | (3.10) | (5.01) | (5.06) | (2.14) | (1.30) | +39.3% | |
| EBITDA | (89.9) | (155.5) | (269.2) | (312.9) | (189.9) | (108.1) | +43.1% | |
| Depreciation & amortization | 1.5 | 1.5 | 2.3 | 7.1 | 6.1 | 7.7 | +25.8% | |
| Weighted average shares (shares) | 45,191,000 | 49,492,000 | 53,832,000 | 63,284,000 | 86,776,000 | 88,791,000 | +2.3% | |
| Weighted average diluted shares (shares) | 45,191,000 | 49,492,000 | 53,832,000 | 63,284,000 | 86,798,000 | 88,791,000 | +2.3% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
